Loading...
Portfolio Diversification
Range
Most Diversified
31 instruments
August 19, 2025
Least Diversified
0 instruments
February 1, 2022
Average
29.1 instruments
Most Consistent Holdings
Top 5
JNJ97.45%
MRK97.45%
PFE97.45%
AMGN97.45%
ABBV97.45%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since February 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Bridgebio (BBIO) | 3.99% | 2.82% | 79.47% | - |
 Guardant Health (GH) | 3.96% | 5.58% | 97.02% | - |
 Eli Lilly (LLY) | 3.71% | 2.94% | 97.45% | - |
 Gilead Sciences (GILD) | 3.28% | 3.16% | 97.45% | - |
| Merck (MRK) | 3.22% | 3.46% | 97.45% | - |
| Johnson & Johnson (JNJ) | 3.21% | 3.19% | 97.45% | - |
 Exact Sciences (EXAS) | 3.13% | 0% | 88.09% | 3/25/2026 |
| AbbVie (ABBV) | 3.08% | 2.7% | 97.45% | - |
| Amgen (AMGN) | 3.08% | 2.99% | 97.45% | - |
 Revolution Medicines (RVMD) | 3.06% | 7.64% | 79.59% | - |
 Regeneron (REGN) | 3.04% | 2.73% | 96.54% | - |
 Vertex (VRTX) | 2.96% | 0% | 82.87% | 12/29/2025 |
 Illumina (ILMN) | 2.94% | 3.52% | 97.02% | - |
 Bristol-Myers Squibb (BMY) | 2.92% | 2.76% | 97.08% | - |
| Pfizer (PFE) | 2.9% | 2.81% | 97.45% | - |
 Exelixis (EXEL) | 2.66% | 2.71% | 75.52% | - |
 Argenx (ARGX) | 2.5% | 2.94% | 79.22% | - |
 ImmunoGen Inc (IMGN) | 2.43% | 0% | 41.62% | 2/14/2024 |
 Syndax (SNDX) | 2.41% | 2.8% | 79.59% | - |
 CRISPR Therapeutics (CRSP) | 2.12% | 0% | 60.69% | 12/26/2024 |
 Arcellx (ACLX) | 1.88% | 0% | 51.15% | 4/30/2026 |
 Blueprint Medicines (BPMC) | 1.85% | 0% | 55.53% | 7/23/2025 |
 Iovance (IOVA) | 1.82% | 0% | 64.95% | 12/29/2025 |
 AstraZeneca (AZN) | 1.77% | 1.92% | 58.38% | - |
 BeiGene (ONC) | 1.46% | 2.48% | 53.22% | - |
 TG Therapeutics (TGTX) | 1.41% | 0% | 40.1% | 12/29/2025 |
 Scholar Rock (SRRK) | 1.31% | 3.92% | 36.76% | - |
 Mirati Therapeutics Inc (MRTX) | 1.23% | 0% | 40.77% | 1/31/2024 |
 Halozyme (HALO) | 1.2% | 3.48% | 36.33% | - |
 Zai Lab (ZLAB) | 1.18% | 0% | 43.2% | 12/29/2025 |
 SpringWorks Therapeutics (SWTX) | 1.18% | 0% | 33.17% | 7/3/2025 |
 BD (BDX) | 1.16% | 0% | 43.86% | 12/29/2025 |
 Crinetics (CRNX) | 1.11% | 0% | 29.59% | 12/29/2025 |
 Fate Therapeutics (FATE) | 0.97% | 0% | 39% | 1/2/2024 |
 Celldex (CLDX) | 0.91% | 3.15% | 35.72% | - |
 Seagen Inc (SGEN) | 0.9% | 0% | 20.23% | 12/18/2023 |
 Merus (MRUS) | 0.88% | 0% | 22.66% | 1/6/2026 |
 Legend Biotech (LEGN) | 0.74% | 0% | 21.14% | 1/2/2024 |
 Incyte (INCY) | 0.73% | 0% | 17.86% | 1/12/2023 |
 BioNTech SE (BNTX) | 0.68% | 0% | 17.86% | 1/12/2023 |
 2Seventy Bio (TSVT) | 0.68% | 0% | 17.86% | 1/12/2023 |
 Option Care Health (OPCH) | 0.67% | 0% | 21.69% | 12/26/2024 |
 Rocket (RCKT) | 0.61% | 0% | 21.69% | 12/26/2024 |
 Arvinas (ARVN) | 0.61% | 0% | 21.69% | 12/26/2024 |
 Agenus (AGEN) | 0.6% | 0% | 17.86% | 1/12/2023 |
 LabCorp (LH) | 0.59% | 0% | 17.86% | 1/12/2023 |
 GlaxoSmithKline (GSK) | 0.55% | 0% | 17.86% | 1/12/2023 |
 MannKind (MNKD) | 0.55% | 0% | 21.14% | 1/2/2024 |
 IDEAYA (IDYA) | 0.53% | 2.64% | 21.63% | - |
 Sorrento (SRNE) | 0.48% | 0% | 17.86% | 1/12/2023 |
 Inovio (INO) | 0.46% | 0% | 17.86% | 1/12/2023 |
 Cogent Biosciences (COGT) | 0.45% | 2.43% | 14.52% | - |
 Clovis Oncology Inc (CLVSQ) | 0.41% | 0% | 16.65% | 12/22/2022 |
 Kura Oncology (KURA) | 0.41% | 3.36% | 13.91% | - |
 Arcus Biosciences (RCUS) | 0.38% | 2.71% | 14.09% | - |
 Janux (JANX) | 0.38% | 0% | 22.17% | 12/29/2025 |
 Nuvalent (NUVL) | 0.35% | 0% | 11.54% | 7/17/2026 |
 Zymeworks (ZYME) | 0.34% | 2.22% | 14.58% | - |
 Olema (OLMA) | 0.34% | 1.21% | 14.58% | - |
 Surface Oncology Inc (SURF) | 0.3% | 0% | 16.65% | 12/22/2022 |
 NeoGenomics (NEO.US) | 0.28% | 4.98% | 6.44% | - |
 Adaptive Biotechnologies (ADPT) | 0.27% | 4.59% | 6.14% | - |
 Invitae Corp (NVTAQ) | 0.22% | 0% | 17.86% | 1/12/2023 |
 Ligand (LGND) | 0.22% | 3.16% | 6.32% | - |
 Curis (CRIS) | 0.21% | 0% | 16.65% | 12/22/2022 |
 Novocure (NVCR) | 0.18% | 0% | 7.84% | 12/29/2025 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Guardant Health (GH) | 1.68% | 4.75% |
| Scholar Rock (SRRK) | 5.61% | 4.2% |
| Revolution Medicines (RVMD) | 1.73% | 3.89% |
| Bridgebio (BBIO) | 0.53% | 3.88% |
| Exact Sciences (EXAS) | 3.33% | 3.86% |
| Syndax (SNDX) | 5.26% | 3.85% |
| Olema (OLMA) | 5.06% | 3.77% |
| Eli Lilly (LLY) | 1.72% | 3.7% |
| Gilead Sciences (GILD) | 2.61% | 3.45% |
| Regeneron (REGN) | 3.95% | 3.42% |
| Cogent Biosciences (COGT) | 4.73% | 3.34% |
| Pfizer (PFE) | 5.63% | 3.31% |
| Merck (MRK) | 3.82% | 3.26% |
| AbbVie (ABBV) | 2.93% | 3.24% |
| Argenx (ARGX) | 2.09% | 3.22% |
| Johnson & Johnson (JNJ) | 3.36% | 3.22% |
| Arcellx (ACLX) | 3.82% | 3.21% |
| Merus (MRUS) | 1.93% | 3.1% |
| IDEAYA (IDYA) | 3.24% | 3.08% |
| Nuvalent (NUVL) | 4.1% | 3.08% |
| Amgen (AMGN) | 2.99% | 3.01% |
| Bristol-Myers Squibb (BMY) | 4.34% | 3% |
| AstraZeneca (AZN) | 2.82% | 2.92% |
| Arcus Biosciences (RCUS) | 3.66% | 2.91% |
| Celldex (CLDX) | 3.62% | 2.9% |
| Halozyme (HALO) | 2.65% | 2.85% |
| Illumina (ILMN) | 3.04% | 2.84% |
| BeiGene (ONC) | 3.75% | 2.82% |
| Exelixis (EXEL) | 1.82% | 2.71% |
| Zymeworks (ZYME) | 3.52% | 2.7% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.